Activation of the Thrombopoietin Receptor by Mutant Calreticulin in CALR-Mutant Myeloproliferative Neoplasms
Results from a recent study indicate that mutant CALR may promote myeloproliferative neoplasm development by activating c-MPL and its downstream pathway.
In The News
Leukemia Foundation MPN News (PDF download)
In The Literature
Biol Blood Marrow Transplant